Rabies vaccine: 4 held as Abhayrab batch fails test

Nifty23, 897.7024.25. Gold (MCX) (Rs/10g.)152, 815.00-2960.0.

Key points

• Rabies Vaccine AbhayrabIndian ImmunologicalsKE25012 vialsCentral Drugs Standard Control Organisationsubstandard vaccinespurious druggovernment immunisation programmes in IndiaHuman Biologicals Instituteabhayrabrabies prevention.
• (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.).
• Govt flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document demonstrates The Central Drugs Standard Control Organisation was called in to collect legal samples.
• Rabies vaccine row: CDSCO flags seized Abhayrab batch was misbranded, 4 arrested after media report.
• While further investigation and legal action are underway, four individuals have been arrested by the Delhi Police in connection with the case.

Nifty23, 897.7024.25. Gold (MCX) (Rs/10g.)152, 815.00-2960.0. The Economic Times daily newspaper is available online now.

Rabies vaccine row: CDSCO flags seized Abhayrab batch was misbranded, 4 arrested after media report. ET OnlineLast Updated: Sep 05, 2026, 08: 37: 00 PM IST.

Notably, a seized batch of rabies vaccine Abhayrab was discovered misbranded and not of standard quality. Delhi Police arrested four individuals in connection with the illegal drug distribution case. The vaccine failed potency tests and indicated packaging discrepancies compared to the manufacturer's sample. Regulators alerted states to monitor the specific vaccine batch and take necessary actions. In practice, the manufacturer stated the seized vials were not produced by their firm. Listen to this article in summarized format. Unlock AI Briefing and Premium Content. New Year Offer 24 Hours Left. Subscribe Now Already a member? Sign In.

Drug regulatory and law enforcement agencies have intensified action against the illegal manufacture and distribution of misbranded drugs after a seized batch of rabies vaccine Abhayrab was discovered to be misbranded and not of standard quality, according to the Central Drugs Standard Control Organisation. While further investigation and legal action are underway, four individuals have been arrested by the Delhi Police in connection with the case. The vaccine, Abhayrab, batch number KE25012, was seized on April 22 from an unlicensed premises in Mukherjee Nagar, Delhi, during a joint search by the Delhi Police Crime Branch and drug inspectors from the Drugs Control Department, Administration of the National Capital Territory of Delhi.

Govt flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document demonstrates The Central Drugs Standard Control Organisation was called in to collect legal samples. It were subsequently sent to the Central Drugs Laboratory in Kasauli for testing. The administration laboratory identified the sample to be "Not of Standard Quality" and "Misbranded" under the Drugs and Cosmetics Act. Live Events.

Although it passed tests for sterility, moisture, thiomersal and identity, the laboratory discovered that the sample failed the potency test. It additionally identified multiple differences between the seized vial and the retained sample of the same batch held by the manufacturer, including differences in packaging artwork, labelling, fonts, logo, QR code, cap colour and hologram. The drug regulator has additionally advised further investigation to establish whether the product meets the definition of a spurious drug under Section 17B of the Drugs and Cosmetics Act. The findings were communicated by the Drugs Controller General of India to states and Union territories. In a communication dated August 27, the regulator asked state drug controllers to alert their inspectorates and maintain strict vigilance over the movement, distribution and availability of batch KE25012 and take regulatory action wherever required. The development comes after a Reuters report highlighted the regulatory action against the rabies vaccine batch. The report remarked the Central Drugs Laboratory had identified the seized vaccine to have failed its potency test and identified discrepancies in its labelling and packaging.: Drug cos refuse to take sole responsibility for overpricing Indian Immunologicals Ltd. It manufactures Abhayrab through its Human Biologicals Institute division, has noted the seized vials were not manufactured by the business. The firm has reaffirmed that every Abhayrab batch is issued only after independent testing and batch-release certification by the Central Drugs Laboratory, Kasauli. According to The manufacturer has additionally, no part of the concerned batch was exported to any other country. The seizure and subsequent regulatory action form part of ongoing surveillance by drug regulators and law enforcement agencies to detect unauthorised manufacture and distribution of drugs. Add Now!

For now, rabies vaccine: 4 held as Abhayrab batch fails test remains the part of the story worth watching, and further updates are likely as more details are confirmed.